Although their role in AD and FTD is uncertain, chaperones like HSP74 and HS105 were decreased, while STIP1 and HSP7C were increased suggesting that protein degradation is facilitated by LMTM treatment. The gene discussed is STIP1; the disease is Alzheimer disease.